The recently-released FDA report entitled, “[FDA] Transparency Initiative: Exploratory Program to Increase Access to the Agency’s Compliance and Enforcement Data,” announced 8 new initiatives adopted as part of FDA’s Transparency Initiative, launched in 2009 by Commissioner Margaret A. Hamburg, MD.
The exploratory transparency initiatives—of which draft proposals were published online and opened to public feedback in October of last year—should serve to promote the public’s understanding of FDA’s decisions and enhance the Agency’s accountability by making data more quickly and readily available, both to industry users and the general public.
The impetus for this report, and the Transparency Initiative in general, comes from Obama’s Presidential Memorandum on Regulatory Compliance, which calls for regulatory agencies such as the FDA “to make public information concerning their regulatory compliance and enforcement activities accessible, downloadable, and searchable online”.
To read more about the new transparency initiatives, click here.